Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
Pacific Biosciences
ISIN US69404D1081
|WKN A1C3EQ
Market cap (in EUR)
467 m
Country
United States
Sector
Healthcare
Dividend yield
0.00%
Overview
Quote
Trade with your broker
Description
Pacific Biosciences of California, Inc. engages in the development, manufacture, and marketing of advanced sequencing solutions for genetic analysis. It operates through the following geographical segments: America, Europe, Middle East, and Africa, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.
Healthcare Healthcare Services Miscellaneous Healthcare United States
Chart
Financials
Key metrics
| Market capitalisation, EUR | 467 m |
| EPS, EUR | -1.97 |
| P/B ratio | 15.2 |
| P/E ratio | - |
| Dividend yield | 0.00% |
Income statement (2024)
| Revenue, EUR | 142 m |
| Net income, EUR | -286 m |
| Profit margin | -201.18% |
What ETF is Pacific Biosciences in?
There are 12 ETFs which contain Pacific Biosciences. All of these ETFs are listed in the table below. The ETF with the largest weighting of Pacific Biosciences is the ARK Genomic Revolution UCITS ETF USD Accumulating.
| ETF | Weight | Investment focus | Fund size (in m EUR) |
|---|---|---|---|
| Global X Telemedicine & Digital Health UCITS ETF Acc USD | 0.68% | Equity World Health Care | 5 |
| ARK Innovation UCITS ETF USD Accumulating | 0.67% | Equity World Innovation | 305 |
| Xtrackers Portfolio UCITS ETF 1C | 0.00% | Equity World Multi-Asset Strategy | 664 |
| ARK Genomic Revolution UCITS ETF USD Accumulating | 1.81% | Equity World Health Care Innovation | 40 |
| Global X Genomics & Biotechnology UCITS ETF | 0.50% | Equity World Health Care Biotech | 17 |
| iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 0.05% | Equity United States Health Care Biotech | 45 |
| iShares Nasdaq US Biotechnology UCITS ETF | 0.05% | Equity United States Health Care Biotech | 749 |
| WisdomTree BioRevolution UCITS ETF USD Acc | 0.46% | Equity World Health Care Social/Environmental Biotech | 8 |
| iShares Healthcare Innovation UCITS ETF | 0.07% | Equity World Health Care Social/Environmental Innovation | 892 |
| Global X Telemedicine & Digital Health UCITS ETF Dist GBP | 0.68% | Equity World Health Care | 0 |
| SPDR Russell 2000 US Small Cap UCITS ETF | 0.02% | Equity United States Small Cap | 3,936 |
| Xtrackers Russell 2000 UCITS ETF 1C | 0.02% | Equity United States Small Cap | 1,865 |
Performance
Returns overview
| YTD | -11.86% |
| 1 month | -18.75% |
| 3 months | +43.12% |
| 6 months | +51.46% |
| 1 year | -15.68% |
| 3 years | -80.60% |
| 5 years | - |
| Since inception (MAX) | -92.95% |
| 2024 | -81.11% |
| 2023 | +20.44% |
| 2022 | -54.58% |
| 2021 | - |
Monthly returns in a heat map
Risk
Risk metrics in this section:
- Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
- Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
- Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.
Risk overview
| Volatility 1 year | 91.11% |
| Volatility 3 years | 92.61% |
| Volatility 5 years | - |
| Return per risk 1 year | -0.17 |
| Return per risk 3 years | -0.45 |
| Return per risk 5 years | - |
| Maximum drawdown 1 year | -60.49% |
| Maximum drawdown 3 years | -93.80% |
| Maximum drawdown 5 years | - |
| Maximum drawdown since inception | -96.86% |
Rolling 1 year volatility
Latest articles
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.